NEW YORK CARDIOTHORACIC TRANSPLANT… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Principal Officer

LEWAY CHEN MD

Phone

5185337870

Tax Period

2024-01-01 to 2024-12-31

NEW YORK CARDIOTHORACIC TRANSPLANT CONSORTIUM INC, founded in 2011, is a small nonprofit in the Diseases & Disorders sector that reported $246K in total revenue in fiscal year 2024. Expenses of $214K left a modest 13% surplus.

Mission

TO BRING TOGETHER HEART AND LUNG TRANSPLANT PROFESSIONALS DEDICATED TO COLLABORATION, DATA SHARING AND PEER REVIEW TO ENHANCE THE QUALITY OF HEART AND LUNG TRANSPLANT SERVICES.

Program Service Accomplishments

Program 1

Expenses: $197,379 Revenue: $235,642

ESTABLISHED IN 2011, THE NEW YORK CARDIOTHORACIC TRANSPLANT CONSORTIUM (NYCTC), A NON-PROFIT ORGANIZATION COMPRISED OF THE SEVEN HEART AND THREE LUNG TRANSPLANT PROGRAM IN NEW YORK STATE, BRINGS...

ESTABLISHED IN 2011, THE NEW YORK CARDIOTHORACIC TRANSPLANT CONSORTIUM (NYCTC), A NON-PROFIT ORGANIZATION COMPRISED OF THE SEVEN HEART AND THREE LUNG TRANSPLANT PROGRAM IN NEW YORK STATE, BRINGS TOGETHER HEART AND LUNG TRANSPLANT PROFESSIONALS DEDICATED TO COLLABORATION, DATA SHARING AND PEER REVIEW TO ENHANCE THE QUALITY OF HEART AND LUNG TRANSPLANT SERVICES. THE NYCTC WORKS TOWARDS THESE GOALS THROUGH ACTIVITIES SUCH AS:PROVIDING ACCURATE AND CURRENT INFORMATION ABOUT HEART AND LUNG TRANSPLANTATION TO NYS TRANSPLANT PROFESSIONALS, RECIPIENTS, DONORS AND FAMILIES,DEVELOPMENT AND REVIEW OF POLICIES TO HELP MAKE THE BEST USE OF THE LIMITED SUPPLY OF ORGANS AND GIVE NYS PATIENTS A FAIR CHANCE AT RECEIVING THE ORGAN THEY NEED, REGARDLESS OF AGE, SEX, ETHNICITY, RELIGION, LIFESTYLE OR FINANCIAL/SOCIAL STATUS.COLLABORATION WITH THE NYS ORGAN PROCUREMENT ORGANIZATIONS TO ENSURE ORGAN ALLOCATION POLICIES ARE FOLLOWED.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $105,894

Program Service Revenue $130,000

Investment Income $9,987

Other Revenue $0

TOTAL REVENUE $245,881

Expense Breakdown

Grants Paid $0

Salaries & Benefits $174,603

Fundraising Expenses $0

Program Expenses $197,379

Other Expenses $39,299

TOTAL EXPENSES $213,902

Year-over-Year Comparison

	2024	2023	Change
Revenue	$245,881	$235,145	+0.0%
Expenses	$213,902	$178,600	+0.2%
Net Income	$31,979	$56,545	-0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARIA AVILA MD	DIRECTOR	0.50	Director	$0	$0	$0
ALAN GASS MD	SECRETARY	1.00	Director	$0	$0	$0
LUIS ANGEL MD	DIRECTOR	0.50	Officer Director	$0	$0	$0
SEAN PINNEY MD	DIRECTOR	0.50	Director	$0	$0	$0
SELIM ARCASOY MD	DIRECTOR	0.50	Director	$0	$0	$0
GABRIEL SAYER MD	DIRECTOR	0.50	Director	$0	$0	$0
LEWAY CHEN MD	TREASURER	1.00	Officer Director	$0	$0	$0
DAVID MAJURE MD	DIRECTOR	0.50	Director	$0	$0	$0
STEVEN FOREST MD	DIRECTOR	0.50	Director	$0	$0	$0
ZACHARY KON MD	PRESIDENT	1.00	Officer Director	$0	$0	$0
SNEHAL PATEL MD	DIRECTOR	0.50	Director	$0	$0	$0
ALEX REYENTOVICH MD	VICE PRESIDENT	1.00	Director	$0	$0	$0
SCOTT SCHEININ MD	DIRECTOR	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$245,881	$213,902	$434,780	$31,979
2023	$235,145	$178,600	$337,343	$56,545
2022	$202,159	$144,139	$258,416	$58,020
2021	$170,038	$132,111	$205,249	$37,927
2020	$159,169	$125,747	$175,538	$33,422
2019	$191,755	$188,303	$125,136	$3,452
2018	$317,134	$321,286	$183,415	$-4,152

NEW YORK CARDIOTHORACIC TRANSPLANT CONSORTIUM INC